Kindmay to Showcase Latest Innovations and Total Solutions at Medlab 2021

Kindmay to Showcase Latest Innovations and Total Solutions at Medlab 2021

2021-07-05 17:15


Shenzhen Kindmay Medical Co., Ltd (Kindmay) showcased its total solutions of COVID-19 with its latest point-of-care testing (POCT) in vitro diagnostic instruments and X-Insight system at Medlab Middle East 2021, an industry-leading medical laboratory exhibition co-located with Arab Health that was held from 21 to 24 June, 2021 in the Dubai World Trade Centre, UAE.

What is Medlab Middle East?

Building on 20 years of Medlab Middle East, the show secures itself as the region’s leading medical laboratory exhibition, Medlab Middle East facilitates the meeting of over 23,000+ medical laboratory, healthcare and trade professionals from 140+ countries.

The show provides a strong business platform both online and live to over 650+ exhibitors from more than 40+ countries, including 14 country pavilions to showcase cutting edge laboratory innovations and solutions.

During Medlab, the company showcased its latest innovations such as rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informative and integrated diagnostics to enhance testing; cutting-edge solutions for microbial identifying and monitoring system among others. Kindmay at the booth welcomed a large number of industry professionals and attracted widespread attention with its high-quality products and turnkey solutions to tackle the region’s ongoing healthcare challenges.



Kindmay X-Insight System offers real-time microbe information monitoring, potential epidemic pre-warning as well as support for abnormal microbe incident processing.

Since early 2020 when COVID-19 first made its appearance and began to spread around the world, technology has played a key role in the global fight against the disease. In line with its mission of promoting health maintenance with technology, Kindmay continues to invest in the R&D of innovative solutions and demonstrates its proven capabilities in leveraging technologies to create new products independently and its commitment to addressing the different needs of customers with a comprehensive lineup of offerings.

With COVID-19 remaining a threat worldwide, Kindmay continues to improve its solutions so that its coronavirus detection products can be used in multiple scenarios.


Kindmay showcased the Portable Ultra-fast Real-Time Quantitative PCR System. The intelligent and easy-to-use product is widely valued by the customers for its detection capabilities in an accurate, fast and secure manner.

The SARS-CoV-2 Rapid Antigen Detection Kit also took center stage among the exhibits. The user-friendly product delivers results within 10 minutes while eliminating the need for additional instruments.

In the post-pandemic era, the health authorities in numerous countries are accelerating the pace of coronavirus vaccinations. With the number of vaccinated people constantly on the rise, Kindmay rolled out a range of solutions used to evaluate the efficacy of vaccines that are already available in the market. The SARS-CoV-2 IgG Antibody Quantitative Test Kit offers precise detection and high-throughput option with 120 test results per hour. Many industry professionals gathered at the booth seeking to get more information about these competitive products.


With the in vitro diagnosis sector growing rapidly, industry players are required to strengthen their capabilities in developing new and unique products at a faster pace. Kindmay is committed to pursuing excellence backed by ongoing innovations and breakthroughs in the field of in vitro diagnosis, while rolling out new products based on market demand and customer feedback as it continues to further broaden its in vitro diagnostic portfolio.

The participation at Medlab Middle East reiterates the Kindmay’s efforts to support the region’s healthcare sector with the latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.

Looking ahead, the company plans to capitalize on its proven products and services to support the global fight against COVID-19 while improving health maintenance and boosting the development of in vitro diagnosis.


Kindmay invites all interested parties to meet again at the Medica Trade Fair in Germany scheduled to take place from 15 to 18 November, 2021.


About Kindmay

Founded in 2000, after 21 years of development, Kindmay has developed into a group corporation specializing in the research and development, manufacturing and sales of IVD reagents and instruments, as well as the operation of the Independent Clinical Laboratories.


  • +852-3500-5196
  • 32nd Floor, Block B, Building 10,
    Shenzhen Bay Science & Technology Ecological Park,
    Nanshan, Shenzhen 518057 China

Mail subscription

Username used for comment:


互联网药品信息服务资格证书[(粤)-非经营性-2023-0167 ]

© 2007-2021 Shenzhen Kindmay Medical Co.,Ltd. All rights reserved.